Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics

Maryam Sayahinouri ^1,2 , Sahar Mashayekhi Firouz ¹ , Amin Ebrahimi Sadrabadi ^3,4 , Mina Masoudnia ⁵ , Mahnaz Abdolahi ⁵ , Fatemeh Jafarzadeh ⁶ , Meshkat Nouripour ⁷ , Sana Mirzazadeh ⁸ , Nazanin Zangeneh ⁹ , Arsalan Jalili ^3,2,10 * , Nasser Aghdami ³

Cited by CrossRef: 1

1- Kerna N, Flores J, Pruitt K, Carsrud N, Ngwu D, Rodriguez D, Holets H, Nwokorie U, Jomsky B, Senat A, Nnake I, Azi C, Saini S, Ukachukwu C, Ezewudo O, Obi M. Hematological Conditions Associated with COVID-19: Pathophysiology, Clinical Manifestations, and Therapeutic Approaches. ejmhr. 2024;2(5):27 [Crossref]

2- Vorobyeva D, Potashnikova D, Maryukhnich E, Rusakovich G, Tvorogova A, Kalinskaya A, Pinegina N, Kovyrshina A, Dolzhikova I, Postnikov A, Rozov F, Sotnikova T, Kanner D, Logunov D, Gintsburg A, Vasilieva E, Margolis L. Cytokine production in an ex vivo model of SARS-CoV-2 lung infection. Front Immunol. 2024;15 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons